aspartic acid has been researched along with Cancer of Ovary in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (29.41) | 18.7374 |
| 1990's | 3 (17.65) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 5 (29.41) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, X; Lv, H; Zhang, Z; Zhou, J | 1 |
| Campanella, A; Canton, M; Carrà, G; Castegna, A; Cormio, G; De Grassi, A; Favia, M; Gerbino, A; Gissi, R; Laera, L; Loizzi, V; Mazzone, M; Menga, A; Pierri, CL; Spera, I; Vegliante, MC | 1 |
| Chen, Y; Deng, H; Ge, R; Jin, L; Li, X; Lian, Q; Wang, J | 1 |
| Bin, P; Dawei, S; Haitao, R; Hang, S; Hongzhi, G; Liying, C; Qiang, L; Qing, L; Weize, K; Yan, H; Yicheng, Z; Yuan, J | 1 |
| Achreja, A; Armaiz-Pena, G; Baddour, J; Baggerly, KA; Bhattacharya, PK; Dalton, HJ; Davies, MA; Eli, MB; Gharpure, KM; Guindani, M; Hu, W; Ivan, C; Liu, J; Lopez-Berestein, G; Lutgendorf, SK; Mangala, LS; McCullough, CR; Mitamura, T; Nagaraja, AS; Nagrath, D; Nick, AM; Pecot, CV; Pradeep, S; Previs, RA; Rodriguez-Aguayo, C; Rupaimoole, R; Shoshan, E; Sood, AK; Wang, Y; Wu, SY; Yang, L; Zacharias, NM; Zand, B | 1 |
| Fu, S; Hu, W; Kavanagh, JJ; Shen, DY; Wei, IC; Yang, DJ; Yu, D; Zheng, H | 1 |
| Blom, HJ; Buurman, WA; Engelke, UF; Hadfoune, M; Heerschap, A; Kolwijck, E; Massuger, LF; van der Graaf, M; Wevers, RA | 1 |
| Blom, HJ; Bulten, J; Engelke, UF; Kolwijck, E; Massuger, LF; Wevers, RA; Woudenberg, J | 1 |
| Ehrlich, CE; Stehman, FB | 1 |
| Bundy, B; Creasman, WT; Muss, HB; Slavik, M; Stehman, FB | 1 |
| Chabner, BA; Donehower, RC; Erlichman, C; Klecker, R; Speyer, JL | 1 |
| Sharma, A; Straubinger, NL; Straubinger, RM | 1 |
| Capizzi, RL; Fernandes, DJ; Wheeler, KT; Yang, JL | 1 |
| Cleaveland, ES; Cooney, DA; Ford, H; Kelley, JA; Paull, K; Zaharevitz, DW | 1 |
| Boonstra, H; Boss, EA; de Jong, JG; Engelke, UF; Massuger, LF; Moolenaar, SH; Wevers, RA | 1 |
| Chan, TC; Howell, SB | 1 |
| Fink, E; Kronberger, L | 1 |
17 other study(ies) available for aspartic acid and Cancer of Ovary
| Article | Year |
|---|---|
Doxorubicin combined with betulinic acid or lonidamine in RGD ligand-targeted pH-sensitive micellar system for ovarian cancer treatment.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Arginine; Aspartic Acid; Betulinic Acid; Cell Line, Tumor; Doxorubicin; Drug Carriers; Drug Compounding; Drug Liberation; Female; Glycine; Humans; Hydrogen-Ion Concentration; Indazoles; Leukocyte Count; Ligands; Mice; Micelles; Oligopeptides; Ovarian Neoplasms; Pentacyclic Triterpenes; Tissue Distribution; Triterpenes; Xenograft Model Antitumor Assays | 2019 |
N-acetylaspartate release by glutaminolytic ovarian cancer cells sustains protumoral macrophages.
Topics: Aspartic Acid; Cell Line, Tumor; Female; Humans; Macrophages; Ovarian Neoplasms; Tumor Microenvironment | 2021 |
Gossypol induces apoptosis in ovarian cancer cells through oxidative stress.
Topics: Apoptosis; Aspartic Acid; Carrier Proteins; Cell Line, Tumor; Chaperonin 60; Contraceptive Agents, Male; Disulfides; Female; Flavin-Adenine Dinucleotide; Gene Expression Profiling; Glutathione; Gossypol; Humans; Membrane Proteins; Metabolomics; Mitochondrial Proteins; Ovarian Neoplasms; Oxidation-Reduction; Oxidative Stress; Proteome; Proteomics; Sulfhydryl Compounds; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2013 |
[Clinical analysis of relapsing anti-N-methyl-D-aspartate receptor encephalitis].
Topics: Adolescent; Adult; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Aspartic Acid; Autoantibodies; Brain Stem; Central Nervous System; Child; Demyelinating Diseases; Female; Humans; Immunotherapy; Intensive Care Units; Magnetic Resonance Imaging; Male; Neuroimaging; Ovarian Neoplasms; Receptors, N-Methyl-D-Aspartate; Recurrence; Retrospective Studies; Teratoma; Young Adult | 2015 |
Role of Increased n-acetylaspartate Levels in Cancer.
Topics: Acetyltransferases; Animals; Apoptosis; Aspartic Acid; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromatography, High Pressure Liquid; Cystadenocarcinoma, Serous; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Mice; Neoplasm Grading; Ovarian Neoplasms; Ovary; Tandem Mass Spectrometry | 2016 |
Diammine dicarboxylic acid platinum enhances cytotoxicity in platinum-resistant ovarian cancer cells through induction of apoptosis and S-phase cell arrest.
Topics: Antineoplastic Agents; Apoptosis; Aspartic Acid; Cell Proliferation; Chondroitin; Cisplatin; Cyclin A; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Humans; Organoplatinum Compounds; Ovarian Neoplasms; S Phase | 2008 |
N-acetyl resonances in in vivo and in vitro NMR spectroscopy of cystic ovarian tumors.
Topics: Adult; Aged; Aspartic Acid; Cyst Fluid; Female; Humans; Magnetic Resonance Spectroscopy; Middle Aged; Nuclear Magnetic Resonance, Biomolecular; Ovarian Cysts; Ovarian Neoplasms; Young Adult | 2009 |
Ovarian cyst fluid of serous ovarian tumors contains large quantities of the brain amino acid N-acetylaspartate.
Topics: Aspartic Acid; Cyst Fluid; Epithelial Cells; Female; Gas Chromatography-Mass Spectrometry; Humans; Neoplasm Proteins; Neoplasms, Glandular and Epithelial; Ovarian Cysts; Ovarian Neoplasms | 2010 |
Peritoneo-cystic shunt for malignant ascites.
Topics: Ascites; Aspartic Acid; Combined Modality Therapy; Female; Fluorouracil; Humans; Middle Aged; Ovarian Neoplasms; Palliative Care; Peritoneum; Phosphonoacetic Acid; Suction; Tamoxifen; Urinary Bladder | 1984 |
A phase II study of PALA (NSC 224131) in patients with advanced ovarian carcinoma. A Gynecologic Oncology Group study.
Topics: Adult; Aged; Aspartic Acid; Blood Cell Count; Drug Evaluation; Female; Humans; Middle Aged; Neoplasm Metastasis; Organophosphorus Compounds; Ovarian Neoplasms; Phosphonoacetic Acid; Skin Diseases; Time Factors | 1984 |
Phase I-phase II trial of N-phosphonacetyl-L-aspartic acid given by intravenous infusion and 5-fluorouracil given by bolus injection.
Topics: Adult; Aged; Antineoplastic Agents; Aspartic Acid; Colonic Neoplasms; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Female; Fluorouracil; Humans; Infusions, Parenteral; Male; Melanoma; Middle Aged; Neoplasms; Organophosphorus Compounds; Ovarian Neoplasms; Pancreatic Neoplasms; Phosphonoacetic Acid; Sarcoma | 1982 |
Modulation of human ovarian tumor cell sensitivity to N-(phosphonacetyl)-L-aspartate (PALA) by liposome drug carriers.
Topics: Antineoplastic Agents; Aspartic Acid; Cell Division; Drug Carriers; Drug Compounding; Female; Humans; Liposomes; Ovarian Neoplasms; Phosphonoacetic Acid; Surface Properties; Tumor Cells, Cultured | 1993 |
PALA enhancement of bromodeoxyuridine incorporation into DNA increases radiation cytotoxicity to human ovarian adenocarcinoma cells.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Aspartic Acid; Bromodeoxyuridine; Cell Division; DNA, Neoplasm; Female; Humans; Nucleotides; Ovarian Neoplasms; Phosphonoacetic Acid; Time Factors; Tumor Stem Cell Assay | 1996 |
Identification of a novel inhibitor (NSC 665564) of dihydroorotate dehydrogenase with a potency equivalent to brequinar.
Topics: Antineoplastic Agents; Aspartic Acid; Biphenyl Compounds; Breast Neoplasms; Carbolines; Carcinoma, Non-Small-Cell Lung; Central Nervous System Neoplasms; Colonic Neoplasms; Dihydroorotate Dehydrogenase; Enzyme Inhibitors; Female; Humans; Kidney Neoplasms; Kinetics; Leukemia; Lung Neoplasms; Male; Melanoma; Mitochondria; Orotic Acid; Ovarian Neoplasms; Oxidoreductases; Oxidoreductases Acting on CH-CH Group Donors; Prostatic Neoplasms; Ribonucleotides; Sodium Bicarbonate; Software; Tumor Cells, Cultured | 1996 |
High-resolution proton nuclear magnetic resonance spectroscopy of ovarian cyst fluid.
Topics: Adult; Amino Acids; Aspartic Acid; Blood Glucose; Body Fluids; Cyst Fluid; Cystadenoma, Serous; Female; Glucose; Humans; Lactic Acid; Magnetic Resonance Spectroscopy; Molecular Weight; Ovarian Cysts; Ovarian Neoplasms; Pyrrolidonecarboxylic Acid; Reference Values | 2000 |
Mechanism of synergy between N-phosphonacetyl-L-aspartate and dipyridamole in a human ovarian carcinoma cell line.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Cell Line; Dipyridamole; Drug Synergism; Female; Humans; Nucleotides; Organophosphorus Compounds; Ovarian Neoplasms; Phosphonoacetic Acid; Uridine | 1985 |
[Potassium-magnesium-aspartate therapy in operated cancer patients].
Topics: Adult; Aged; Anemia, Hypochromic; Aspartic Acid; Body Weight; Breast Neoplasms; Female; Hemoglobinometry; Humans; Ketoglutaric Acids; Long-Term Care; Magnesium; Male; Middle Aged; Ovarian Neoplasms; Postoperative Care; Potassium; Rectal Neoplasms; Rehabilitation; Retroperitoneal Neoplasms; Stomach Neoplasms; Thyroid Neoplasms; Tongue Neoplasms | 1971 |